Table 2 Monitor of the alteration of haemostasis in the patient with RPL.
Parameters (Unit of measurement) | First screening | Second screening | Third screening | Fourth screening | Normal value |
|---|---|---|---|---|---|
aPTT (ratio) | 1.45 | 1.36 | 1.28 | 1.44 | 0.8–1.2 |
Factor XII (%) | 65 | 50 | 55 | 43 | 80–120 |
Anticardiolipin Ab IgM (U/MPL) | 1.7 | 1.3 | 1.5 | 1.5 | < 2.0 |
Anticardiolipin Ab IgG (U/GPL) | 3.9 | 5.4 | 3.8 | 2.5 | < 7.0 |
β-2-GP I Ab | Absent | Absent | Absent | Absent | Absent |
Lupus anticoagulant | Absent | Absent | Present | Absent | Absent |
Anti-factor XII Ab | Not tested | Not tested | Not tested | Present | Absent |
Antinuclear antibodies (ANA) | Absent | Not tested | Not tested | Absent | Not tested |